share on google plus
Text size
view with small font size
view with medium font size
view with large font size

Leaping Forward Together

Kyowa Hakko Kirin will continue to strive to be a Japan-based world-leading R&D type life science company contributing to the health and comfort of people around the world. Utilizing our unique technological capability and human resources, we will introduce new drugs into the European and the U.S. markets to contribute to the world.
Kyowa Kirin Group has set a target of "leaping forward for Global Specialty Pharmaceutical Company (GSP)" as our Mid-term Business Plan for the period from 2016 to 2020.

To Page Top